首页   >  
Angiogenesis/Protein Tyrosine Kinase
  • Jak/Stat Pathway
  >  
EGFR
  • HER2
  >   卡奈替尼
Canertinib 结构式

卡奈替尼

参考资料 仅供科学研究,不可用于个人用途。
货号 :BCP01790CAS号 :267243-28-7纯度:98%
全国免运费!免费咨询:400-099-8200 或 手机联系:13472751340
即时询价 ×

* 必填项

请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • 基本信息与产品描述
CAS号 267243-28-7 货号 BCP01790
关联产品 289499-45-2(卡奈替尼两盐酸盐)
中文名 卡奈替尼
英文名 Canertinib
中文别名 卡那替尼;卡纽替尼;卡拉替尼;
英文别名 PD-183805;CI1033;CI-1033;CI 1033;PD 183805;PD183805;
SMILES
化学名称
分子式 C24H25ClFN5O3 分子量 485.94
纯度 98% 配送 惯例下常温包邮
产品描述 Canertinib, also known as CI1033 and PD183805, is a potent ErbB inhibitor for the treatment of cancer. It is an irreversible tyrosine-kinase inhibitor with activity against EGFR (IC50 0.8 nM), HER-2 (IC50 19 nM) and ErbB-4 (IC50 7 nM). By 2015, Pfizer had discontinued development of the drug. Canertinib has been reported as a substrate for OATP1B3. Interaction of canertinib with OATP1B3 may alter its hepatic disposition and can lead to transporter mediated drug-drug interactions. Also, canertinib is not an inhibitor of OATP-1B1 or OATP-1B3 transporter.
  • 技术资料和支持
在购买和使用瀚香生物产品的过程中,您遇到的任何问题,都可以咨询我们的免费热线:400-099-8200,或者和我们的客服 。 我们竭诚解决您的一切疑惑,保证您的舒心顺畅。

相关产品推荐

查看更多 >

Tags:Canertinib 供应商,Canertinib 购买,Canertinib 生产,Canertinib 批量,Canertinib 供应,Canertinib 订购,Canertinib 采购

2853530910